Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 3507
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2401
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Julien Taieb Karine Le Malicot Frederique Madeleine Penault-Llorca Olivier Bouche Qian Shi Stephen N. Thibodeau Josep Tabernero Enrico Mini Richard M. Goldberg Gunnar Folprecht Jean-Luc Van Laethem Daniel J. Sargent Steven R. Alberts Pierre Laurent-Puig Frank A. Sinicrope
- Networks:
- LAPS-MN026, LAPS-OH007
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: